8 Diabetes Drug Updates

January 17, 2020



The year 2020 comes primed with 2019's approvals and expanded indications for drugs to treat patients with diabetes. From novel formulations of and delivery mechanisms for glucagon for hypoglycemia to indications for renal and cardiovascular protection for sodium-glucose co-transporter 2 inhibitors and the first oral glucagon-like peptide-1 analog, the options available to help optimize diabetes care continue to expand.Review 8 of the important updates from 2019 in the short slide show below.